Salts of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide

Details for Australian Patent Application No. 2007257962 (hide)

Owner Novartis AG

Inventors Stowasser, Frank; Karpinski, Piotr; Slade, Joel; Acemoglu, Murat; Bajwa, Joginder S.; Papoutsakis, Dimitris

Agent Davies Collison Cave

Pub. Number AU-B-2007257962

PCT Pub. Number WO2007/146715

Priority 60/804,523 12.06.06 US; 60/869,993 14.12.06 US

Filing date 7 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 23 June 2011

International Classifications

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4045 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/146715 Priority application(s): WO2007/146715

23 June 2011 Application Accepted

  Published as AU-B-2007257962

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257967-Microwavable bag or sheet material

2007257959-Therapy using cytokine inhibitors